Paul F. Lizzul insider trades

Open-market stock purchases and sales by Paul F. Lizzul, Chief Medical Officer at First Tracks Biotherapeutics, Inc, from SEC Form 4 filings since Jul 26, 2017.

Recent trades

DateStockTradeValue
Aug 15, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Aug 2, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
May 12, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
May 12, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Mar 12, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 8, 2026ANAB Anaptysbio, IncSold$163K
Jan 7, 2026ANAB Anaptysbio, IncSold$101K
Jan 7, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 6, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 6, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 6, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 5, 2026ANAB Anaptysbio, IncSold$183K
Jan 3, 2026ANAB Anaptysbio, IncBought (not open market)—
Dec 22, 2025ANAB Anaptysbio, IncSold$75K

Companies traded

  • TRAX First Tracks Biotherapeutics, Inc: other filings, last Aug 15, 2026
  • ANAB Anaptysbio, Inc: 10 sales, last Mar 12, 2026
  • SNNA Sienna Biopharmaceuticals, Inc: 1 buy, last Aug 6, 2019

Get free alerts when Paul F. Lizzul files a new trade →